| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 2, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 5,466 | $17.92 | $97,974.22 | View Details Filing |
| Jan 7, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 1,450 | $23.88 | $34,620.49 | View Details Filing |
| Jan 7, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 3,707 | $23.24 | $86,158.84 | View Details Filing |
| Jan 7, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 309 | $24.57 | $7,593.24 | View Details Filing |
| Jan 5, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | S | 10,135 | $15.17 | $153,747.95 | View Details Filing |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | A | 90,000 | - | - | View Details Filing |
| Jan 2, 2026 | Monte Rosa Therapeutics, Inc. (GLUE) | A | 406,000 | $0.00 | $0.00 | View Details Filing |